Press Release | NeoGenomics Laboratories

October 22, 2024

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

October 15, 2024

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

October 8, 2024

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

September 23, 2024

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation

September 11, 2024

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

August 29, 2024

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

July 29, 2024

NeoGenomics Reports Second Quarter 2024 Results

July 9, 2024

NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients